Respiratory Commensal Bacteria Increase Protection against Hypermucoviscous Carbapenem-Resistant Klebsiella pneumoniae ST25 Infection

• Published in: Pathogens (Basel) 2022-09, Vol.11 (9), p.1063
• Main Authors: Dentice Maidana, Stefania, Ortiz Moyano, Ramiro, Vargas, Juan, Fukuyama, Kohtaro, Kurata, Shoichiro, Melnikov, Vyacheslav, Jure, María, Kitazawa, Haruki, Villena, Julio
• Format: Article
• Language: English
• Subjects: antibiotic resistance; Antibiotics; Antimicrobial agents; Bacteria; Carbapenemase; Communication; Corynebacterium pseudodiphtheriticum; Experiments; Immune response; Immune system; Immunomodulation; Innate immunity; Interleukin 10; Intranasal administration; Klebsiella; Klebsiella pneumoniae; Laboratory animals; Leukocyte migration; Leukocytes; Lungs; Microorganisms; next generation probiotics; Nosocomial infections; Pathogens; Probiotics; respiratory commensal bacteria; respiratory immunity; Respiratory syncytial virus; Respiratory tract; Strains (organisms); Streptococcus infections; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Virulence; γ-Interferon
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens11091063

In a previous work, we demonstrated that nasally administered Corynebacterium pseudodiphtheriticum 090104 beneficially modulated the respiratory innate immune response and improved the protection against Respiratory Syncytial Virus and Streptococcus pneumoniae in mice. In this work, we aimed to evaluate whether the immunomodulatory 090104 strain was able to enhance the resistance against the respiratory infection induced by hypermucoviscous carbapenemase-producing (KPC-2) Klebsiella pneumoniae strains belonging to the sequence type (ST) 25. The nasal treatment of mice with C. pseudodiphtheriticum 090104 before the challenge with multiresistant K. pneumoniae ST25 strains significantly reduced lung bacterial cell counts and lung tissue damage. The protective effect of the 090104 strain was related to its ability to regulate the respiratory innate immune response triggered by K. pneumoniae challenge. C. pseudifteriticum 090104 differentially modulated the recruitment of leukocytes into the lung and the production of TNF-α, IFN-γ and IL-10 levels in the respiratory tract and serum. Our results make an advance in the positioning of C. pseudodiphtheriticum 090104 as a next-generation probiotic for the respiratory tract and encourage further research of this bacterium as a promising alternative to develop non-antibiotic therapeutical approaches to enhance the prevention of infections produced by microorganisms with multiple resistance to antimicrobials such as KPC-2-producing hypermucoviscous K. pneumoniae strains belonging to ST25.